Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.83B | 1.83B | 1.54B | 1.48B | 1.07B | Gross Profit |
487.39M | 501.95M | 414.45M | 471.26M | 284.58M | EBIT |
90.63M | 102.45M | 39.26M | 143.85M | -226.28M | EBITDA |
160.68M | 53.50M | 237.57M | 266.08M | -97.78M | Net Income Common Stockholders |
-203.70M | -194.21M | 49.52M | 75.07M | -258.45M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.40B | 1.24B | 1.20B | 1.89B | 1.82B | Total Assets |
4.13B | 4.50B | 4.75B | 4.73B | 4.58B | Total Debt |
357.62M | 456.94M | 475.02M | 117.97M | 139.88M | Net Debt |
-833.78M | -575.14M | -496.92M | -792.48M | -930.95M | Total Liabilities |
746.56M | 881.82M | 896.09M | 504.94M | 456.51M | Stockholders Equity |
2.98B | 3.24B | 3.49B | 3.86B | 3.81B |
Cash Flow | Free Cash Flow | |||
0.00 | 229.79M | -5.46M | 151.00M | 3.75M | Operating Cash Flow |
0.00 | 247.53M | 31.73M | 170.95M | 39.05M | Investing Cash Flow |
0.00 | -20.95M | 587.77M | -261.67M | -742.86M | Financing Cash Flow |
0.00 | -151.07M | -518.45M | -90.80M | -93.68M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | $22.03B | 11.22 | 4.96% | 0.36% | 1.31% | 379.84% | |
66 Neutral | $455.99M | 3.32 | 7.60% | ― | 76.15% | 334.56% | |
58 Neutral | HK$303.64M | 14.47 | 2.73% | 3.50% | -0.69% | ― | |
54 Neutral | $5.38B | 3.40 | -45.06% | 3.28% | 16.75% | -0.02% | |
53 Neutral | HK$205.37M | ― | -29.08% | ― | 23.58% | 0.50% | |
52 Neutral | $9.10B | ― | -9.66% | ― | -44.43% | -281.08% | |
50 Neutral | HK$1.54B | ― | -6.55% | 0.53% | 0.04% | -4.88% |
Town Health International Medical Group Ltd. has announced its annual general meeting scheduled for June 6, 2025, where key business matters will be addressed. These include the adoption of financial statements, declaration of a final dividend, re-election of directors, and re-appointment of auditors. The meeting will also consider resolutions to empower directors to manage share allotments and related financial instruments, potentially impacting the company’s capital structure and shareholder value.
Town Health International Medical Group Ltd. announced a final cash dividend of HKD 0.0012 per share for the financial year ending December 31, 2024. The dividend will be paid on September 12, 2025, following shareholder approval on June 6, 2025. This announcement updates previous information regarding book closure and record dates, reflecting the company’s commitment to shareholder returns.
Town Health International Medical Group Ltd. reported its annual results for the year ended December 31, 2024, with a slight increase in revenue to approximately HK$1,833,795,000 compared to the previous year. Despite this, the company recorded a net loss of approximately HK$158,207,000, slightly improved from the previous year’s loss. The Board recommended maintaining a final dividend of Hong Kong 0.12 cent per share. The company’s financial position showed a decrease in net assets and a stable current ratio and gearing ratio, indicating a steady financial structure despite the losses.
Town Health International Medical Group Ltd. has announced a final ordinary cash dividend of HKD 0.0012 per share for the financial year ending December 31, 2024. This announcement signifies the company’s commitment to returning value to its shareholders, reflecting its stable financial performance and strategic position in the healthcare sector.
Town Health International Medical Group Ltd. has announced that its board of directors will meet on March 28, 2025, to approve the company’s final results for the year ending December 31, 2024, and to consider recommending a final dividend. This meeting is crucial for stakeholders as it will determine the company’s financial performance and potential dividend payouts, impacting investor confidence and market positioning.
Town Health International Medical Group Ltd. announced the resignation of Mr. Liu Shiyin as an executive director due to other business commitments, with no disagreements reported with the board. To fill the vacancy, Mr. Huang Yu has been appointed as an executive director effective February 24, 2025. Mr. Huang brings a wealth of experience in business investment and management, having held significant positions in China Life-related companies. His appointment is expected to bolster the group’s investment strategies and operational leadership, potentially impacting its market positioning positively.
Town Health International Medical Group Limited has announced the composition of its board of directors and the roles and functions of its members. The announcement outlines the structure of the board, listing executive, non-executive, and independent non-executive directors, as well as detailing the membership of three board committees: Audit, Nomination, and Remuneration. This release provides clarity on the governance and leadership structure of the company, potentially impacting the company’s strategic direction and enhancing transparency for stakeholders.